ALEC compared with SLN: revenue, margins and what each company keeps, and the suppliers and customers both name

ALECAlector, Inc.

Mkt capRevenueRevenue

SLNSilence Therapeutics plc

Mkt capRevenueRevenue

Compare

ALECAlector, Inc.

SLNSilence Therapeutics plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ALEC 3

ABBVAbbViecustomer

GSKGlaxoSmithKlinecustomer

—Adimabunlistedsupplier

Shared 0

No shared counterparties.

Only SLN 2

AZNAstraZeneca ABcustomer

—Hansoh Pharmaceuticalunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ALECAlector, Inc.

2.12▼−4.28%

Mkt cap$246.8MRevenue$3MQ2 FY26Revenue$21MFY25

SLNSilence Therapeutics plc

19.78▲+0.15%

Regular sessionNov 2 '26

Mkt cap$933.1MRevenue$422,000Q1 FY26Revenue$559,000FY25

Compare

Regular sessionNov 2 '26

ALECAlector, Inc.

SLNSilence Therapeutics plc

2.12▼−4.28%

Price

19.78▲+0.15%

$246.8M

Mkt cap

$933.1M

Q2 FY26$3M

Revenue

$422,000Q1 FY26

FY25$21M

Revenue

$559,000FY25

ALEC2.12▼−4.28%vsSLN19.78▲+0.15%Regular sessionNov 2 '26